Private Vaccination & Clinical Service Prices | Hampstead, London NW3

*Price includes consultation & private prescription

We provide acetazolamide to prevent altitude illness for suitable individuals, subject to consultation. This service will help you effectively prevent Altitude Sickness, ensuring you can safely enjoy your holiday.

Altitude illness occurs when ascending rapidly to high altitudes (typically above 2,500m). Severe altitude illness is a life-threatening condition.

For more detailed information, read the CDC Yellow Book on High-Altitude Travel and Altitude Illness.

TD is the most common health problem affecting overseas travellers. Our service will help you effectively prevent and manage Travellers’ Diarrhoea (TD) so you can fully enjoy your holiday.

Stand-by antibiotics, such as azithromycin, are strictly for those at high risk of severe illness or visiting high-risk areas, supplied following a consultation.

Note: Studies of probiotics to prevent TD are ongoing, but data are insufficient to recommend their use.

Learn more via the CDC Guidelines on Travellers' Diarrhoea.

• Proguanil 100mg / Atovaquone 250mg tablets: £2.50 per tablet
• Proguanil 25mg / Atovaquone 62.5mg tablets (Paediatric): £1.40 per tablet
• Doxycycline 100mg capsules: £0.50 per capsule
• Mefloquine 250mg tablets: £4.80 per tablet

For further guidance, visit the TravelHealthPro Factsheet on Malaria.

We administer BCG AJV, the only BCG vaccine licensed in the UK and used by the NHS.
A Mantoux test is required prior to BCG for individuals aged 6+, or children under 6 with prolonged stays in high-risk countries.

For more details, visit our dedicated BCG & TB Testing page.

2026 NHS Policy: Children will receive a combined MMRV vaccine on the NHS. Eligibility varies heavily by birthdate. Children born on or before 31 Dec 2019 are NOT eligible and can only access varicella vaccination privately. A single MMRV catch-up dose will be offered on the NHS to children born between 1 January 2020 and 31 August 2022 (from November 2026 to March 2028), provided they have not had chickenpox or two doses of varicella vaccine.

Read more on our dedicated Chickenpox vaccine page.

We provide Vimkonya®, a non-live chikungunya vaccine. Traditional mosquito avoidance methods alone are not necessarily sufficient against day-biting Aedes mosquitoes.

Find more details on the TravelHealthPro Factsheet on Chikungunya.

In clinical trials, the cholera vaccine (Dukoral) has shown efficacy against Enterotoxigenic Escherichia coli (ETEC), a common cause of travellers’ diarrhoea. Please note, Dukoral is prescribed off-label for this indication. Strict food and water hygiene remain essential.

Learn more via the TravelHealthPro Factsheet on Cholera.

Why do we give tetanus boosters to travellers? While five doses provide lifetime cover in the UK, this assumes easy access to emergency medical care. We provide boosters for travellers to regions where medical facilities and emergency tetanus immunoglobulin may be limited.

Why Choose Ambirix?

• Fewer Injections: It simplifies long-term protection, requiring only two injections instead of five (if giving Hep A & Hep B separately).
• Cost-Effective: Works out less expensive overall than individual course bookings.

Dose Timings & Delays

• The second dose should ideally be given within 6–12 months after the first dose.
• Delayed Doses: Although second doses delayed beyond this window fall outside the product licence, evidence shows that a delayed second dose still significantly boosts the immune response. There is no maximum interval requiring you to restart a course.

Read the official guidance for Hepatitis A and Hepatitis B.

Private COVID-19 Vaccination

We offer the updated 2025-26 Pfizer mRNA vaccine privately. Suitable for all eligible individuals, including pregnant women.

NHS COVID-19 Vaccination (Spring 2026 Programme)

We are participating in the NHS seasonal spring 2026 programme for COVID-19 vaccination.

Eligible Cohorts

• Individuals aged 75 years and over (including individuals who turn 75 years old by 30 June 2026).
• Residents in a care home for older adults (as defined through CQC registration), irrespective of the individual's age.
• Individuals aged 18 years and over who are immunosuppressed.

Programme Dates

• COVID-19 vaccinations will commence on 13 April 2026 and will end on 30 June 2026.
• The national booking service and 119 telephone booking service will be open for the public to make bookings from 7 April 2026 to 29 June 2026.

The Green Book notes that, exceptionally, Qdenga® may be considered for individuals who have not had dengue in the past, where the potential benefits are judged to outweigh the risks after individual clinical assessment. In such cases, the theoretical risk of severe dengue should be clearly explained to the patient.

For more details, visit the TravelHealthPro Factsheet on Dengue.

We provide a range of combination vaccines depending on age and requirements:

• 6-in-1 (Vaxelis): £150. Interchangeable with Infanrix hexa. For children from 6 weeks.
• 5-in-1 (Infanrix-IPV+Hib): £108. Suitable from 2 months to 3 years.
• 4-in-1 (Repevax / Tdap-IPV): £100. Suitable from 3 years+.

If a specific Haemophilus influenzae type b (Hib) vaccine is required, the Hib/MenC vaccine (Menitorix) is available for £118 (Suitable from 1 year of age).

For additional details regarding routine childhood immunisations, review the UK Complete Routine Immunisation Schedule.

Private Flu Vaccinations

Influenza has been described as the most frequent vaccine preventable infection among travellers to tropical and subtropical countries.

All but one of the influenza vaccines currently used in the UK are inactivated. The vaccines do not cause clinical influenza in those who are vaccinated. One vaccine, the intranasally administered vaccine (a nasal spray squirted up each nostril), contains attenuated (weakened), cold adapted viruses, which cannot replicate at body temperature. The live virus vaccine may cause symptoms of a mild cold.

Following vaccination, protection is thought to last for at least three to six months. After vaccination, protective immune responses may be achieved within 14 days.

Read more via the TravelHealthPro Factsheet on Influenza.

NHS Flu Vaccinations

If your child was born before 1 August 2017, it is highly recommended they receive the Hepatitis A and B combined vaccine. Given as two doses 6-12 months apart, it effectively immunises them against both infectious diseases.

Incomplete courses: If you received one dose years ago, you do not need to restart the course. A single dose now will complete it.

If your child was born before 1 August 2017, it is highly recommended they receive the Hepatitis A and B combined vaccine. Given as two doses 6-12 months apart, it effectively immunises them against both infectious diseases.

Schedules: Standard (0, 1, 6 months) or Rapid (0, 7, 21 days & 12 months) used when time is short prior to travel.

Find out more on our dedicated HPV vaccination page.

Minimum Dose Intervals

• Standard schedule: 0 & 28 days.
• Rapid schedule: 0 & 7 days. This is licensed for adults (18-65 years) as per the Green Book, and is ideal for travellers leaving in less than one month.

Unlicensed rapid schedule use: For children (from two months of age) and adults aged 65 years and older, the rapid schedule is not licensed due to a lack of data. However, it can be used in circumstances where there is genuinely insufficient time to complete the standard schedule prior to travel. There are no data to suggest that the rapid schedule would be harmful for these travellers.

For more detailed information, please read the TravelHealthPro Factsheet on Japanese Encephalitis.

We supply Adaflex 3mg tablets (30 tablets), used for the short-term treatment of jet lag in adults. This is a medical-grade melatonin.

For additional strategies on managing circadian rhythms, visit the CDC Yellow Book: Jet Lag Disorder.

Our comprehensive weight management programme includes unlimited 1-to-1 coaching & support from our clinical team. Learn more here.

Meningococcal disease, including meningitis and septicaemia, can occur at any age, which is why many parents choose to secure protection for their children as early as possible.

We offer the MenACWY vaccine privately, with Nimenrix® available from 6 weeks of age and MenQuadfi® from 12 months — well ahead of the NHS routine offer at age 14.

Certification is available if required at no extra charge (e.g., for Hajj/Umrah).

Intervals with other vaccines:

• Yellow Fever & MMR: Must be 4 weeks apart. In urgent circumstances where protection is needed rapidly, both may be given at any interval; an additional dose of MMR should then be considered (Green Book Ch.35).
• Chickenpox & MMR: If not given on same day, must be 4 weeks apart.
• Mantoux & MMR: Delay MMR until skin test is read.

Pneumococcal pneumonia is a potentially serious bacterial lung disease. We offer multiple vaccine options based on age and previous NHS immunisations:

• Prevenar 13 (PCV13): £109. Suitable from 6 weeks of age. Part of the current NHS childhood vaccination schedule.
• Prevenar 20 (PCV20): £117 (or £106 depending on risk profile). Suitable from 6 weeks of age.
• Pneumovax 23 (PPV23): £77. Suitable from 2 years of age.

For more detailed information regarding immunisation timings, view the UKHSA Complete Routine Immunisation Schedule.

Intradermal (ID) Injection: £55 per dose

The 1-week, 4-dose regimen (MHRA approved 2024 / WHO endorsed). Given as 4 doses over 2 appointments with a 7-day interval (1 dose in both arms per visit).

Intramuscular (IM) Injection: £110 per dose

Conventional (0, 7, 21 days) or Rapid (0, 3, 7 & 365 days) schedules available.

Rabies Booster Guidance

Pre-exposure (travellers and at-risk occupations): After completing a full primary course, most healthy travellers do not require routine booster doses. In the UK, current guidance is to base any future boosters on individual risk and, where relevant, antibody testing rather than automatic time-based boosters.

Ongoing high-risk exposure: People with continued high risk (e.g. certain laboratory staff, bat handlers) may need periodic serology and boosters if antibody levels fall below recommended thresholds, as advised by occupational health or a specialist clinic.

Post-exposure: Booster (or completion) doses after a bite or significant exposure are given according to national post-exposure protocols, which depend on the person’s previous vaccination history, the type of exposure and the animal involved.

Private Adult & Maternal RSV Vaccination (£240 per dose)

Timing & Revaccination

• Best Time to Vaccinate: Late summer/early autumn, before the RSV season peaks in the winter.
• Booster Guidance: Protection wanes to 48% by the third season. Revaccination may be considered after a minimum of 24 months following your initial dose (for self-paying patients, per UK Green Book guidance). We recommend booking a consultation to discuss this.

For a full list of side effects, please see the official patient leaflet.

NHS RSV Vaccination

As of 2025–26, the NHS programme covers pregnant women (28–36 weeks) and adults aged 75 to 79. From April 2026, eligibility expands to include adults aged 80+ and older adult care home residents.

Beyfortus is a long-acting monoclonal antibody reducing the risk of RSV hospitalisation in infants by almost 80%. Please review the UK Official Patient Leaflet (PIL).

For additional details regarding childhood immunisations, review the UK Complete Routine Immunisation Schedule.

We utilise the new, highly effective non-live shingles vaccine (Shingrix). No matter how healthy you feel, your immune system declines with age, putting you at an increased risk for shingles. 1 in 3 people will get shingles in their lifetime.

For more detailed information, please read our dedicated Shingles vaccine page.

Boosters: A booster is recommended every 3-5 years for those at ongoing risk.

The top 7 countries with the highest prevalence of Tick-borne encephalitis are Lithuania, Latvia, Estonia, the Czech Republic, Slovenia, Sweden, and Austria.

For more details, visit the TravelHealthPro Factsheet on TBE.

• Oral Capsules: A live vaccine given as 3 doses on alternate days (suitable from 5 years of age).
• Injection: A single-dose, non-live vaccine (suitable from 2 years of age).

We can vaccinate children between the ages of 12 months and two years off-label if following a detailed risk assessment the risk of typhoid fever is considered high. Immunisation is not recommended for children under one year of age. When children are too young to benefit fully from typhoid vaccination, scrupulous attention to personal, food and water hygiene measures should be exercised by the caregiver.

Find out more via the TravelHealthPro Factsheet on Typhoid.

Usually required for US visa clearance or for 'cocooning'—vaccinating close contacts of a newborn to protect the baby from pertussis. We provide this vaccine's certification at no extra cost.

About the Disease & Protection

• The Risk: A viral disease transmitted by mosquitoes, ranging from mild to severe. There is no treatment; care focuses solely on symptom management.
• Prevention: Strict mosquito bite avoidance and vaccination are strongly recommended for travellers visiting risk areas.

Certification & Requirements

• Mandatory Entry: Under International Health Regulations, a certificate may be a mandatory entry requirement for certain countries—even if the actual disease risk is low for your specific itinerary.
• Authorised Centres: The vaccine is exclusively available at designated UK Yellow Fever Vaccination Centres (YFVCs), like Hampstead Heath Pharmacy.

For more information, please review the TravelHealthPro Factsheet on Yellow Fever.

Certificate Guidelines

• Standard Validity: Existing International Certificates of Vaccination or Prophylaxis (ICVP) with a 10-year validity are acceptable under International Health Regulations and do not routinely need reissuing.
• Replacements: We can issue a replacement ICVP if your original is genuinely lost, badly damaged, or subject to a verified name change, provided an accurate medical record of the previous vaccination can be seen.
• Lost Records: If you have lost your certificate and do not possess the official dates and batch numbers, the only legally acceptable approach for immigration authorities is to repeat the vaccination.
• Medical Exemptions: We can issue medical letters of exemption from the ICVP when clinically appropriate.

For additional details, visit the NaTHNaC Factsheet on the ICVP or check the NaTHNaC Yellow Fever Vaccine Recommendation Maps.